Insulin and Insulin-Like Growth Factor 1 Signaling Preserves Sarcomere Integrity in the Adult Heart

REFERENCES

• Ikeda H, Shiojima I, Ozasa Y, Yoshida M, Holzenberger M, Kahn CR, Walsh K, Igarashi T, Abel ED, Komuro I. 2009. Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. J Mol Cell Cardiol 47:664–675. https://doi.org/10.1016/j.yjmcc.2009.08.028.
   PubMed Web of Science ®Google Scholar
• Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, Wayment BE, Litwin SE, Holzenberger M, LeRoith D, Abel ED. 2008. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol 22:2531–2543. https://doi.org/10.1210/me.2008-0265.
   PubMedGoogle Scholar
• Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED. 2002. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629–639. https://doi.org/10.1172/JCI13946.
   PubMed Web of Science ®Google Scholar
• Boudina S, Bugger H, Sena S, O’Neill BT, Zaha VG, Ilkun O, Wright JJ, Mazumder PK, Palfreyman E, Tidwell TJ, Theobald H, Khalimonchuk O, Wayment B, Sheng X, Rodnick KJ, Centini R, Chen D, Litwin SE, Weimer BE, Abel ED. 2009. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119:1272–1283. https://doi.org/10.1161/CIRCULATIONAHA.108.792101.
   PubMed Web of Science ®Google Scholar
• Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE. 2003. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285:H1261–H1269. https://doi.org/10.1152/ajpheart.00108.2003.
   PubMed Web of Science ®Google Scholar
• McQueen AP, Zhang D, Hu P, Swenson L, Yang Y, Zaha VG, Hoffman JL, Yun UJ, Chakrabarti G, Wang Z, Albertine KH, Abel ED, Litwin SE. 2005. Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. J Mol Cell Cardiol 39:882–892. https://doi.org/10.1016/j.yjmcc.2005.07.017.
   PubMed Web of Science ®Google Scholar
• Sena S, Hu P, Zhang D, Wang X, Wayment B, Olsen C, Avelar E, Abel ED, Litwin SE. 2009. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J Mol Cell Cardiol 46:910–918. https://doi.org/10.1016/j.yjmcc.2009.02.014.
   PubMed Web of Science ®Google Scholar
• Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, Kahn CR. 2007. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol 27:1649–1664. https://doi.org/10.1128/MCB.01110-06.
   PubMed Web of Science ®Google Scholar
• Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, III, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190. https://doi.org/10.1038/372186a0.
   PubMed Web of Science ®Google Scholar
• Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186. https://doi.org/10.1038/372182a0.
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904. https://doi.org/10.1038/36116.
   PubMed Web of Science ®Google Scholar
• Riehle C, Wende AR, Zhu Y, Oliveira KJ, Pereira RO, Jaishy BP, Bevins J, Valdez S, Noh J, Kim BJ, Moreira AB, Weatherford ET, Manivel R, Rawlings TA, Rech M, White MF, Abel ED. 2014. Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Mol Cell Biol 34:3450–3460. https://doi.org/10.1128/MCB.00426-14.
   PubMed Web of Science ®Google Scholar
• Riehle C, Wende AR, Sena S, Pires KM, Pereira RO, Zhu Y, Bugger H, Frank D, Bevins J, Chen D, Perry CN, Dong XC, Valdez S, Rech M, Sheng X, Weimer BC, Gottlieb RA, White MF, Abel ED. 2013. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J Clin Invest 123:5319–5333. https://doi.org/10.1172/JCI71171.
   PubMed Web of Science ®Google Scholar
• Long YC, Cheng Z, Copps KD, White MF. 2011. Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol Cell Biol 31:430–441. https://doi.org/10.1128/MCB.00983-10.
   PubMed Web of Science ®Google Scholar
• Qi Y, Xu Z, Zhu Q, Thomas C, Kumar R, Feng H, Dostal DE, White MF, Baker KM, Guo S. 2013. Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38alpha MAPK during insulin resistance. Diabetes 62:3887–3900. https://doi.org/10.2337/db13-0095.
   PubMed Web of Science ®Google Scholar
• Desbois-Mouthon C, Wendum D, Cadoret A, Rey C, Leneuve P, Blaise A, Housset C, Tronche F, Le Bouc Y, Holzenberger M. 2006. Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20:773–775. https://doi.org/10.1096/fj.05-4704fje.
   PubMed Web of Science ®Google Scholar
• Bugger H, Riehle C, Jaishy B, Wende AR, Tuinei J, Chen D, Soto J, Pires KM, Boudina S, Theobald HA, Luptak I, Wayment B, Wang X, Litwin SE, Weimer BC, Abel ED. 2012. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol 52:1019–1026. https://doi.org/10.1016/j.yjmcc.2012.02.001.
   PubMed Web of Science ®Google Scholar
• Miano JM, Long X, Fujiwara K. 2007. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292:C70–C81. https://doi.org/10.1152/ajpcell.00386.2006.
   PubMed Web of Science ®Google Scholar
• Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, Concordet JP, Paulin D, Li Z, Daegelen D. 2004. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol 24:5281–5289. https://doi.org/10.1128/MCB.24.12.5281-5289.2004.
   PubMed Web of Science ®Google Scholar
• Niu Z, Yu W, Zhang SX, Barron M, Belaguli NS, Schneider MD, Parmacek M, Nordheim A, Schwartz RJ. 2005. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J Biol Chem 280:32531–32538. https://doi.org/10.1074/jbc.M501372200.
   PubMed Web of Science ®Google Scholar
• Parlakian A, Charvet C, Escoubet B, Mericskay M, Molkentin JD, Gary-Bobo G, De Windt LJ, Ludosky MA, Paulin D, Daegelen D, Tuil D, Li Z. 2005. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 112:2930–2939. https://doi.org/10.1161/CIRCULATIONAHA.105.533778.
   PubMed Web of Science ®Google Scholar
• Sun Q, Chen G, Streb JW, Long X, Yang Y, Stoeckert CJ, Jr, Miano JM. 2006. Defining the mammalian CArGome. Genome Res 16:197–207. https://doi.org/10.1101/gr.4108706.
   PubMed Web of Science ®Google Scholar
• Qi Y, Zhu Q, Zhang K, Thomas C, Wu Y, Kumar R, Baker KM, Xu Z, Chen S, Guo S. 2015. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and beta-myosin heavy chain gene expression. Circ Heart Fail 8:198–208. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001457.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Soto J, Anderson B, Riehle C, Zhang YC, Wende AR, Jones D, McClain DA, Abel ED. 2013. Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1alpha. Am J Physiol Heart Circ Physiol 305:H41–H51. https://doi.org/10.1152/ajpheart.00877.2012.
   PubMed Web of Science ®Google Scholar
• Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F, Krishnan J, Lerch R, Hall MN, Ruegg MA, Pedrazzini T, Brink M. 2011. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123:1073–1082. https://doi.org/10.1161/CIRCULATIONAHA.110.977066.
   PubMed Web of Science ®Google Scholar
• Zhang D, Contu R, Latronico MVG, Zhang J, Zhang JL, Rizzi R, Catalucci D, Miyamoto S, Huang K, Ceci M, Gu Y, Dalton ND, Peterson KL, Guan K-L, Brown JH, Chen J, Sonenberg N, Condorelli G. 2010. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 120:2805–2816. https://doi.org/10.1172/JCI43008.
   PubMed Web of Science ®Google Scholar
• Ock S, Lee WS, Kim HM, Park KS, Kim YK, Kook H, Park WJ, Lee TJ, Abel ED, Kim J. 2018. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts. Biochim Biophys Acta Mol Basis Dis 1864:1183–1191. https://doi.org/10.1016/j.bbadis.2018.01.022.
   PubMed Web of Science ®Google Scholar
• Laird DW. 2006. Life cycle of connexins in health and disease. Biochem J 394:527–543. https://doi.org/10.1042/BJ20051922.
   PubMed Web of Science ®Google Scholar
• Martin AF. 1981. Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem 256:964–968. https://doi.org/10.1016/S0021-9258(19)70073-8.
   PubMed Web of Science ®Google Scholar
• Michele DE, Albayya FP, Metzger JM. 1999. Thin filament protein dynamics in fully differentiated adult cardiac myocytes: toward a model of sarcomere maintenance. J Cell Biol 145:1483–1495. https://doi.org/10.1083/jcb.145.7.1483.
   PubMed Web of Science ®Google Scholar
• Clark WA, Jr, Zak R. 1981. Assessment of fractional rates of protein synthesis in cardiac muscle cultures after equilibrium labeling. J Biol Chem 256:4863–4870. https://doi.org/10.1016/S0021-9258(19)69335-X.
   PubMed Web of Science ®Google Scholar
• Morkin E, Kimata S, Skillman JJ. 1972. Myosin synthesis and degradation during development of cardiac hypertrophy in the rabbit. Circ Res 30:690–702. https://doi.org/10.1161/01.res.30.6.690.
   PubMed Web of Science ®Google Scholar
• Martin AF, Rabinowitz M, Blough R, Prior G, Zak R. 1977. Measurements of half-life of rat cardiac myosin heavy chain with leucyl-tRNA used as precursor pool. J Biol Chem 252:3422–3429. https://doi.org/10.1016/S0021-9258(17)40408-X.
   PubMed Web of Science ®Google Scholar
• Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851–862. https://doi.org/10.1016/s0092-8674(01)00404-4.
   PubMed Web of Science ®Google Scholar
• Madonna R, Geng YJ, Bolli R, Rokosh G, Ferdinandy P, Patterson C, De Caterina R. 2014. Co-activation of nuclear factor-kappaB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts. J Biol Chem 289:19585–19598. https://doi.org/10.1074/jbc.M113.540559.
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, Kuroda S. 2000. ENH, containing PDZ and LIM domains, heart/skeletal muscle-specific protein, associates with cytoskeletal proteins through the PDZ domain. Biochem Biophys Res Commun 272:505–512. https://doi.org/10.1006/bbrc.2000.2787.
   PubMed Web of Science ®Google Scholar
• Cheng H, Kimura K, Peter AK, Cui L, Ouyang K, Shen T, Liu Y, Gu Y, Dalton ND, Evans SM, Knowlton KU, Peterson KL, Chen J. 2010. Loss of enigma homolog protein results in dilated cardiomyopathy. Circ Res 107:348–356. https://doi.org/10.1161/CIRCRESAHA.110.218735.
   PubMed Web of Science ®Google Scholar
• Liang Y, Bradford WH, Zhang J, Sheikh F. 2018. Four and a half LIM domain protein signaling and cardiomyopathy. Biophys Rev 10:1073–1085. https://doi.org/10.1007/s12551-018-0434-3.
   PubMedGoogle Scholar
• Arimura T, Hayashi T, Matsumoto Y, Shibata H, Hiroi S, Nakamura T, Inagaki N, Hinohara K, Takahashi M, Manatsu SI, Sasaoka T, Izumi T, Bonne G, Schwartz K, Kimura A. 2007. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem Biophys Res Commun 357:162–167. https://doi.org/10.1016/j.bbrc.2007.03.128.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Hayashi T, Inagaki N, Takahashi M, Hiroi S, Nakamura T, Arimura T, Nakamura K, Ashizawa N, Yasunami M, Ohe T, Yano K, Kimura A. 2005. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil 26:367–374. https://doi.org/10.1007/s10974-005-9018-5.
   PubMed Web of Science ®Google Scholar
• Friedrich FW, Reischmann S, Schwalm A, Unger A, Ramanujam D, Munch J, Muller OJ, Hengstenberg C, Galve E, Charron P, Linke WA, Engelhardt S, Patten M, Richard P, van der Velden J, Eschenhagen T, Isnard R, Carrier L. 2014. FHL2 expression and variants in hypertrophic cardiomyopathy. Basic Res Cardiol 109:451. https://doi.org/10.1007/s00395-014-0451-8.
   PubMed Web of Science ®Google Scholar
• Kong Y, Shelton JM, Rothermel B, Li X, Richardson JA, Bassel-Duby R, Williams RS. 2001. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 103:2731–2738. https://doi.org/10.1161/01.CIR.103.22.2731.
   PubMed Web of Science ®Google Scholar
• Hojayev B, Rothermel BA, Gillette TG, Hill JA. 2012. FHL2 binds calcineurin and represses pathological cardiac growth. Mol Cell Biol 32:4025–4034. https://doi.org/10.1128/MCB.05948-11.
   PubMed Web of Science ®Google Scholar
• Eckardt D, Kirchhoff S, Kim JS, Degen J, Theis M, Ott T, Wiesmann F, Doevendans PA, Lamers WH, de Bakker JM, van Rijen HV, Schneider MD, Willecke K. 2006. Cardiomyocyte-restricted deletion of connexin43 during mouse development. J Mol Cell Cardiol 41:963–971. https://doi.org/10.1016/j.yjmcc.2006.07.017.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Pires KM, Whitehead KJ, Olsen CD, Wayment B, Zhang YC, Bugger H, Ilkun O, Litwin SE, Thomas G, Kozma SC, Abel ED. 2013. Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One 8:e54221. https://doi.org/10.1371/journal.pone.0054221.
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Mahdavi V. 1989. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 84:1693–1700. https://doi.org/10.1172/JCI114351.
   PubMed Web of Science ®Google Scholar
• Shimizu I, Minamino T, Toko H, Okada S, Ikeda H, Yasuda N, Tateno K, Moriya J, Yokoyama M, Nojima A, Koh GY, Akazawa H, Shiojima I, Kahn CR, Abel ED, Komuro I. 2010. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Invest 120:1506–1514. https://doi.org/10.1172/JCI40096.
   PubMed Web of Science ®Google Scholar
• Riehle C, Weatherford ET, Wende AR, Jaishy BP, Seei AW, McCarty NS, Rech M, Shi Q, Reddy GR, Kutschke WJ, Oliveira K, Pires KM, Anderson JC, Diakos NA, Weiss RM, White MF, Drakos SG, Xiang YK, Abel ED. 2020. Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. JCI Insight 5:e134920. https://doi.org/10.1172/jci.insight.134920.
   Google Scholar
• Wende AR, O’Neill BT, Bugger H, Riehle C, Tuinei J, Buchanan J, Tsushima K, Wang L, Caro P, Guo A, Sloan C, Kim BJ, Wang X, Pereira RO, McCrory MA, Nye BG, Benavides GA, Darley-Usmar VM, Shioi T, Weimer BC, Abel ED. 2015. Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes. Mol Cell Biol 35:831–846. https://doi.org/10.1128/MCB.01109-14.
   PubMed Web of Science ®Google Scholar
• Yenush L, White MF. 1997. The IRS-signalling system during insulin and cytokine action. Bioessays 19:491–500. https://doi.org/10.1002/bies.950190608.
   PubMed Web of Science ®Google Scholar
• Weigert C, Hennige AM, Lehmann R, Brodbeck K, Baumgartner F, Schauble M, Haring HU, Schleicher ED. 2006. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. J Biol Chem 281:7060–7067. https://doi.org/10.1074/jbc.M509782200.
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Hilfiker A, Drexler H. 2005. Many good reasons to have STAT3 in the heart. Pharmacol Ther 107:131–137. https://doi.org/10.1016/j.pharmthera.2005.02.003.
   PubMed Web of Science ®Google Scholar
• Yan H, Yang W, Zhou F, Pan Q, Allred K, Allred C, Sun Y, Threadgill D, Dostal D, Tong C, Guo S. 2022. Estrogen protects cardiac function and energy metabolism in dilated cardiomyopathy induced by loss of cardiac IRS1 and IRS2. Circ Heart Fail 15:e008758. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008758.
   Google Scholar
• Valencik ML, McDonald JA. 2001. Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Res 10:269–275. https://doi.org/10.1023/a:1016601928465.
   PubMed Web of Science ®Google Scholar
• Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF. 2008. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65–76. https://doi.org/10.1016/j.cmet.2008.06.006.
   PubMed Web of Science ®Google Scholar
• Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF. 2004. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114:908–916. https://doi.org/10.1172/JCI22217.
   PubMed Web of Science ®Google Scholar
• Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559–569. https://doi.org/10.1016/s1097-2765(00)80155-0.
   PubMed Web of Science ®Google Scholar
• El Accaoui RN, Gould ST, Hajj GP, Chu Y, Davis MK, Kraft DC, Lund DD, Brooks RM, Doshi H, Zimmerman KA, Kutschke W, Anseth KS, Heistad DD, Weiss RM. 2014. Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 306:H1302–H1313. https://doi.org/10.1152/ajpheart.00392.2013.
   PubMed Web of Science ®Google Scholar
• Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. 2006. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 114:2065–2069. https://doi.org/10.1161/CIRCULATIONAHA.106.634139.
   PubMed Web of Science ®Google Scholar
• Riehle C, Wende AR, Zaha VG, Pires KM, Wayment B, Olsen C, Bugger H, Buchanan J, Wang X, Moreira AB, Doenst T, Medina-Gomez G, Litwin SE, Lelliott CJ, Vidal-Puig A, Abel ED. 2011. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res 109:783–793. https://doi.org/10.1161/CIRCRESAHA.111.243964.
   PubMed Web of Science ®Google Scholar
• Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B, Yang J, Moore SA, Scholz TD, Strack S, Mohler PJ, Sivitz WI, Song LS, Anderson ME. 2012. CaMKII determines mitochondrial stress responses in heart. Nature 491:269–273. https://doi.org/10.1038/nature11444.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550. https://doi.org/10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar